title: AstraZeneca pays $520m fine for off label marketing.
authors.forename: Janice Hopkins
authors.initials: JH
authors.lastname: Tanne
mesh_terms: D014150:Antipsychotic Agents / Q000191:economics*; D003987:Dibenzothiazepines / Q000191:economics*; D004345:Drug Industry / Q000191:economics / Q000331:legislation & jurisprudence*; D006801:Humans; D008389:Marketing of Health Services / Q000191:economics / Q000331:legislation & jurisprudence*; D001523:Mental Disorders / Q000188:drug therapy* / Q000191:economics; D056687:Off-Label Use / Q000191:economics*; D000069348:Quetiapine Fumarate
chemical_list: D014150:Antipsychotic Agents; D003987:Dibenzothiazepines; D000069348:Quetiapine Fumarate